| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.78B | 22.59B | 23.66B | 21.84B | 20.53B | 18.97B |
| Gross Profit | 4.01B | 3.91B | 4.43B | 3.25B | 3.89B | 3.33B |
| EBITDA | 2.31B | 2.21B | 2.88B | 1.81B | 2.61B | 2.28B |
| Net Income | 163.19M | 486.28M | 1.32B | 291.52M | 1.35B | 974.70M |
Balance Sheet | ||||||
| Total Assets | 30.39B | 30.49B | 32.43B | 28.05B | 27.36B | 26.75B |
| Cash, Cash Equivalents and Short-Term Investments | 8.72B | 8.59B | 9.68B | 7.23B | 6.95B | 8.08B |
| Total Debt | 2.19B | 2.59B | 2.93B | 2.05B | 1.58B | 2.79B |
| Total Liabilities | 8.65B | 8.42B | 10.75B | 8.32B | 8.05B | 8.96B |
| Stockholders Equity | 21.74B | 22.07B | 21.68B | 19.74B | 19.31B | 17.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -525.50M | 1.43B | -557.81M | -68.67M | 719.19M |
| Operating Cash Flow | 0.00 | 677.70M | 3.88B | 1.06B | 1.74B | 2.78B |
| Investing Cash Flow | 0.00 | -1.39B | -2.17B | -1.48B | -1.34B | -1.74B |
| Financing Cash Flow | 0.00 | -705.31M | 394.22M | 159.06M | -1.55B | 1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥18.75B | 8.04 | ― | 2.70% | -8.63% | -55.68% | |
71 Outperform | ¥4.22B | 60.43 | ― | 4.08% | 3.46% | ― | |
70 Outperform | ¥8.30B | 5.20 | ― | 3.54% | -0.72% | -72.70% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥8.11B | 4.65 | ― | 4.24% | -7.88% | -73.98% | |
57 Neutral | ¥18.89B | 18.77 | ― | 3.19% | -8.99% | -62.26% | |
52 Neutral | ¥10.83B | 0.59 | ― | ― | -9.54% | 21.21% |